KYNB KYNTRA BIO, INC.
Nasdaq · SEC CIK 921299 · EDGAR
- Bought, last 12 months
- $33.8K 3 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 176 since 2021-07-08, latest 2026-09-09 20:42
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Wettig Thane | CEO, Dir | $33.8K | — |
| DeLucia David | CFO | — | — |
Transactions 174
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-10 | 2023-03-08+ | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $20.62 | -56.3K | 356.1K | -14% | -$1.16M |
| M | 2023-03-10 | 2023-03-08+ | KYNB | Graham Juan | CFO | S - Sale | $20.54 | -7,661 | 72.9K | -10% | -$157.4K |
| M | 2023-03-10 | 2023-03-08 | KYNB | Graham Juan | CFO | A - Grant | $0.00 | +7,567 | 77.8K | +11% | $0 |
| M | 2023-03-10 | 2023-03-08 | KYNB | Eisner Mark | Chief Medical Off | A - Grant | $0.00 | +20.2K | 185.3K | +12% | $0 |
| M | 2023-03-10 | 2023-03-08+ | KYNB | Eisner Mark | Chief Medical Off | S - Sale | $20.60 | -17.5K | 165.1K | -10% | -$360.6K |
| 2023-03-06 | 2023-03-02 | KYNB | Eisner Mark | Chief Medical Off | S - Sale | $21.87 | -1,187 | 172.5K | -0.7% | -$26.0K | |
| D | 2023-02-23 | 2023-02-21 | KYNB | Conterno Enrique A | CEO, Dir | A - Grant | $0.00 | +85.3K | 380.8K | +29% | $0 |
| D | 2023-02-23 | 2023-02-21 | KYNB | Graham Juan | CFO | A - Grant | $0.00 | +25.0K | 73.0K | +52% | $0 |
| D | 2023-02-23 | 2023-02-21 | KYNB | Chung Christine | SVP, China Ops | A - Grant | $0.00 | +25.0K | 259.9K | +11% | $0 |
| D | 2023-02-23 | 2023-02-21 | KYNB | Wettig Thane | Chief Commercial Off | A - Grant | $0.00 | +25.0K | 110.4K | +29% | $0 |
| D | 2023-02-23 | 2023-02-21 | KYNB | Eisner Mark | Chief Medical Off | A - Grant | $0.00 | +32.5K | 173.7K | +23% | $0 |
| 2023-01-10 | 2023-01-06 | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $19.95 | -1,538 | 295.5K | -0.5% | -$30.7K | |
| A | 2023-01-04 | 2022-12-08 | KYNB | Chung Christine | SVP, China Ops | S - Sale | $15.79 | -2,595 | 234.9K | -1% | -$41.0K |
| A | 2023-01-04 | 2022-09-06 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $12.26 | -1,851 | 242.2K | -0.8% | -$22.7K |
| 2022-12-28 | 2022-12-23 | KYNB | Wettig Thane | Chief Commercial Off | S - Sale | $15.80 | -734 | 89.2K | -0.8% | -$11.6K | |
| M | 2022-12-15 | 2022-12-08 | KYNB | Graham Juan | CFO | S - Sale | $14.89 | -5,741 | 50.6K | -10% | -$85.5K |
| MA | 2022-12-15 | 2022-12-09+ | KYNB | Graham Juan | CFO | S - Sale | $14.64 | -2,188 | 48.0K | -4% | -$32.0K |
| M | 2022-12-14 | 2022-12-09+ | KYNB | Graham Juan | CFO | S - Sale | $14.64 | -2,188 | 55.1K | -4% | -$32.0K |
| 2022-12-09 | 2022-12-08 | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $15.79 | -2,543 | 297.0K | -0.8% | -$40.2K | |
| 2022-12-09 | 2022-12-08 | KYNB | Wettig Thane | Chief Commercial Off | S - Sale | $15.79 | -382 | 89.9K | -0.4% | -$6,032 | |
| 2022-12-09 | 2022-12-08 | KYNB | Chung Christine | SVP, China Ops | S - Sale | $15.79 | -1,096 | 237.7K | -0.5% | -$17.3K | |
| 2022-12-02 | 2022-12-01 | KYNB | Eisner Mark | Chief Medical Off | F - Tax | $15.04 | -1,084 | 141.2K | -0.8% | -$16.3K | |
| 2022-10-11 | 2022-10-06 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $14.26 | -1,296 | 299.6K | -0.4% | -$18.5K | |
| 2022-10-04 | 2022-09-30 | KYNB | Eisner Mark | Chief Medical Off | F - Tax | $13.01 | -6,777 | 142.3K | -5% | -$88.2K | |
| 2022-10-04 | 2022-09-30 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $13.01 | -4,683 | 238.8K | -2% | -$60.9K | |
| 2022-09-26 | 2022-09-22 | KYNB | Wettig Thane | Chief Commercial Off | F - Tax | $12.26 | -655 | 90.3K | -0.7% | -$8,030 | |
| 2022-09-08 | 2022-09-06 | KYNB | Wettig Thane | Chief Commercial Off | F - Tax | $12.26 | -360 | 90.9K | -0.4% | -$4,414 | |
| 2022-09-08 | 2022-09-07 | KYNB | Graham Juan | CFO | F - Tax | $12.62 | -3,009 | 55.9K | -5% | -$38.0K | |
| 2022-09-08 | 2022-09-06 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $12.26 | -1,772 | 300.9K | -0.6% | -$21.7K | |
| 2022-09-08 | 2022-09-06 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $12.26 | -518 | 243.5K | -0.2% | -$6,351 | |
| 2022-09-02 | 2022-09-01 | KYNB | Eisner Mark | Chief Medical Off | F - Tax | $13.09 | -756 | 149.0K | -0.5% | -$9,896 | |
| 2022-07-08 | 2022-07-06 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $12.40 | -1,296 | 302.6K | -0.4% | -$16.1K | |
| 2022-06-24 | 2022-06-22 | KYNB | Wettig Thane | Chief Commercial Off | F - Tax | $11.42 | -655 | 91.3K | -0.7% | -$7,480 | |
| D | 2022-06-21 | 2022-06-16 | KYNB | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +15.8K | 33.6K | +89% | $0 |
| D | 2022-06-21 | 2022-06-16 | KYNB | Brennan Aoife | Dir | A - Grant | $0.00 | +15.8K | 24.4K | +183% | $0 |
| D | 2022-06-21 | 2022-06-16 | KYNB | EDWARDS JEFFREY L | Dir | A - Grant | $0.00 | +15.8K | 33.6K | +89% | $0 |
| D | 2022-06-21 | 2022-06-16 | KYNB | Ho Maykin | Dir | A - Grant | $0.00 | +15.8K | 31.7K | +99% | $0 |
| D | 2022-06-21 | 2022-06-16 | KYNB | Schoeneck James A | Dir | A - Grant | $0.00 | +15.8K | 20.5K | +336% | $0 |
| D | 2022-06-21 | 2022-06-16 | KYNB | Blaug Suzanne | Dir | A - Grant | $0.00 | +15.8K | 29.8K | +112% | $0 |
| D | 2022-06-21 | 2022-06-16 | KYNB | Cravatt Benjamin | Dir | A - Grant | $0.00 | +15.8K | 24.4K | +183% | $0 |
| D | 2022-06-21 | 2022-06-16 | KYNB | Lema Gerald | Dir | A - Grant | $0.00 | +15.8K | 20.5K | +336% | $0 |
| 2022-06-08 | 2022-06-06 | KYNB | Wettig Thane | Chief Commercial Off | F - Tax | $9.50 | -360 | 90.0K | -0.4% | -$3,420 | |
| 2022-06-08 | 2022-06-06 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $9.50 | -1,850 | 244.0K | -0.8% | -$17.6K | |
| 2022-06-08 | 2022-06-06 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $9.50 | -1,772 | 301.9K | -0.6% | -$16.8K | |
| 2022-06-03 | 2022-06-01 | KYNB | Eisner Mark | Chief Medical Off | F - Tax | $9.61 | -1,141 | 149.8K | -0.8% | -$11.0K | |
| 2022-04-08 | 2022-04-07 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $12.73 | -1,311 | 303.7K | -0.4% | -$16.7K | |
| 2022-04-01 | 2022-03-31 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $12.02 | -4,682 | 245.9K | -2% | -$56.3K | |
| 2022-04-01 | 2022-03-31 | KYNB | Eisner Mark | Chief Medical Off | F - Tax | $12.02 | -6,442 | 150.9K | -4% | -$77.4K | |
| 2022-03-24 | 2022-03-22 | KYNB | Wettig Thane | Chief Commercial Off | F - Tax | $13.31 | -655 | 90.3K | -0.7% | -$8,718 | |
| 2022-03-09 | 2022-03-07 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $12.69 | -3,905 | 250.5K | -2% | -$49.6K | |
| 2022-03-09 | 2022-03-07 | KYNB | Wettig Thane | Chief Commercial Off | F - Tax | $12.69 | -1,706 | 91.0K | -2% | -$21.6K | |
| 2022-03-09 | 2022-03-07 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $12.69 | -7,081 | 305.0K | -2% | -$89.9K | |
| 2022-03-03 | 2022-03-01 | KYNB | Eisner Mark | Chief Medical Off | F - Tax | $13.62 | -756 | 157.4K | -0.5% | -$10.3K | |
| D | 2022-02-16 | 2022-02-14 | KYNB | Eisner Mark | Chief Medical Off | A - Grant | $0.00 | +60.0K | 158.1K | +61% | $0 |
| D | 2022-02-16 | 2022-02-14 | KYNB | Chung Christine | SVP, China Ops | A - Grant | $0.00 | +45.0K | 254.4K | +21% | $0 |
| D | 2022-02-16 | 2022-02-14 | KYNB | Wettig Thane | Chief Commercial Off | A - Grant | $0.00 | +45.0K | 92.7K | +94% | $0 |
| D | 2022-02-16 | 2022-02-14 | KYNB | Conterno Enrique A | CEO, Dir | A - Grant | $0.00 | +179.4K | 312.1K | +135% | $0 |
| D | 2022-02-16 | 2022-02-14 | KYNB | Graham Juan | CFO | A - Grant | $0.00 | +22.5K | 58.9K | +62% | $0 |
| 2022-01-07 | 2022-01-06 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $13.93 | -1,536 | 132.7K | -1% | -$21.4K | |
| 2022-01-05 | 2022-01-03 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $14.82 | -5,284 | 209.4K | -2% | -$78.3K | |
| 2022-01-05 | 2022-01-03 | KYNB | Eisner Mark | Chief Medical Off | F - Tax | $14.82 | -7,043 | 98.1K | -7% | -$104.4K | |
| 2021-12-23 | 2021-12-22 | KYNB | Wettig Thane | Chief Commercial Off | F - Tax | $14.97 | -517 | 47.7K | -1% | -$7,739 | |
| 2021-12-08 | 2021-12-06 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $14.19 | -2,668 | 214.7K | -1% | -$37.9K | |
| 2021-12-03 | 2021-12-01 | KYNB | Eisner Mark | Chief Medical Off | F - Tax | $12.65 | -4,338 | 105.2K | -4% | -$54.9K | |
| 2021-10-08 | 2021-10-06 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $10.20 | -1,859 | 134.2K | -1% | -$19.0K | |
| D | 2021-10-06 | 2021-10-04 | KYNB | Eisner Mark | Chief Medical Off | A - Grant | $0.00 | +74.5K | 109.5K | +213% | $0 |
| D | 2021-10-06 | 2021-10-04 | KYNB | Chung Christine | SVP, China Ops | A - Grant | $0.00 | +54.2K | 217.4K | +33% | $0 |
| 2021-09-24 | 2021-09-22 | KYNB | Wettig Thane | Chief Commercial Off | F - Tax | $10.18 | -620 | 48.2K | -1% | -$6,312 | |
| 2021-09-17 | 2021-09-15 | KYNB | KEARNS THOMAS F JR | Dir | S - Sale | $11.58 | -13.1K | 39.8K | -25% | -$151.7K | |
| D | 2021-09-09 | 2021-09-07 | KYNB | Graham Juan | CFO | A - Grant | $0.00 | +35.0K | 36.4K | +2,500% | $0 |
| 2021-09-09 | 2021-09-07 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $12.41 | -2,030 | 165.3K | -1% | -$25.2K | |
| 2021-09-09 | 2021-09-07 | KYNB | Cotroneo Pat | Executive Advisor, Former CFO | F - Tax | $12.41 | -2,141 | 274.5K | -0.8% | -$26.6K | |
| 2021-08-30 | 2021-08-26 | KYNB | Wettig Thane | Chief Commercial Off | P - Purchase | $11.53 | +3,100 | 48.8K | +7% | +$35.7K | |
| 2021-07-08 | 2021-07-06 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $25.06 | -1,859 | 136.1K | -1% | -$46.6K |
Purchase Sale Sale after option exercise All abbreviations